PURPOSE OF REVIEW: The interplay between circadian rhythm and cancer has been suggested for more than a decade based on the observations that shift work and cancer incidence are linked. Accumulating evidence implicates the circadian clock in cancer survival and proliferation pathways. At the molecular level, multiple control mechanisms have been proposed to link circadian transcription and cell-cycle control to tumorigenesis. RECENT FINDINGS: The circadian gating of the cell cycle and subsequent control of cell proliferation is an area of active investigation. Moreover, the circadian clock is a transcriptional system that is intricately regulated at the epigenetic level. Interestingly, the epigenetic landscape at the level of histone modifications, DNA methylation, and small regulatory RNAs are differentially controlled in cancer cells. This concept raises the possibility that epigenetic control is a common thread linking the clock with cancer, though little scientific evidence is known to date. SUMMARY: This review focuses on the link between circadian clock and cancer, and speculates on the possible connections at the epigenetic level that could further link the circadian clock to tumor initiation or progression.
PURPOSE OF REVIEW: The interplay between circadian rhythm and cancer has been suggested for more than a decade based on the observations that shift work and cancer incidence are linked. Accumulating evidence implicates the circadian clock in cancer survival and proliferation pathways. At the molecular level, multiple control mechanisms have been proposed to link circadian transcription and cell-cycle control to tumorigenesis. RECENT FINDINGS: The circadian gating of the cell cycle and subsequent control of cell proliferation is an area of active investigation. Moreover, the circadian clock is a transcriptional system that is intricately regulated at the epigenetic level. Interestingly, the epigenetic landscape at the level of histone modifications, DNA methylation, and small regulatory RNAs are differentially controlled in cancer cells. This concept raises the possibility that epigenetic control is a common thread linking the clock with cancer, though little scientific evidence is known to date. SUMMARY: This review focuses on the link between circadian clock and cancer, and speculates on the possible connections at the epigenetic level that could further link the circadian clock to tumor initiation or progression.
Authors: Agustin Chicas; Avnish Kapoor; Xiaowo Wang; Ozlem Aksoy; Adam G Evertts; Michael Q Zhang; Benjamin A Garcia; Emily Bernstein; Scott W Lowe Journal: Proc Natl Acad Sci U S A Date: 2012-05-21 Impact factor: 11.205
Authors: Ping Chen; Colles Price; Zejuan Li; Yuanyuan Li; Donglin Cao; Anissa Wiley; Chunjiang He; Sandeep Gurbuxani; Rejani B Kunjamma; Hao Huang; Xi Jiang; Stephen Arnovitz; Mengyi Xu; Gia-Ming Hong; Abdel G Elkahloun; Mary Beth Neilly; Mark Wunderlich; Richard A Larson; Michelle M Le Beau; James C Mulloy; Paul P Liu; Janet D Rowley; Jianjun Chen Journal: Proc Natl Acad Sci U S A Date: 2013-06-24 Impact factor: 11.205
Authors: Utham K Valekunja; Rachel S Edgar; Malgorzata Oklejewicz; Gijsbertus T J van der Horst; John S O'Neill; Filippo Tamanini; Daniel J Turner; Akhilesh B Reddy Journal: Proc Natl Acad Sci U S A Date: 2013-01-07 Impact factor: 11.205
Authors: Anne-Laure Huber; Stephanie J Papp; Alanna B Chan; Emma Henriksson; Sabine D Jordan; Anna Kriebs; Madelena Nguyen; Martina Wallace; Zhizhong Li; Christian M Metallo; Katja A Lamia Journal: Mol Cell Date: 2016-11-10 Impact factor: 17.970
Authors: Linda A Toth; Rita A Trammell; Teresa Liberati; Steve Verhulst; Marcia L Hart; Jacob E Moskowitz; Craig Franklin Journal: Comp Med Date: 2017-03-01 Impact factor: 0.982